Erlong Zhang

2.6k total citations · 1 hit paper
37 papers, 2.2k citations indexed

About

Erlong Zhang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Erlong Zhang has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 11 papers in Genetics. Recurrent topics in Erlong Zhang's work include Cancer, Hypoxia, and Metabolism (16 papers), High Altitude and Hypoxia (11 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Erlong Zhang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (16 papers), High Altitude and Hypoxia (11 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Erlong Zhang collaborates with scholars based in China, United States and Saudi Arabia. Erlong Zhang's co-authors include Chunmeng Shi, Shenglin Luo, Yongping Su, Tianmin Cheng, Xu Tan, Yuqi Gao, Gang Xu, Jian Chen, Chao Zhang and Bao Liu and has published in prestigious journals such as Biomaterials, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Erlong Zhang

33 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of NIR dyes in cancer targeting and imaging

2011 1.2k citations Shenglin Luo, Erlong Zhang et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erlong Zhang China	17	1.1k	675	651	442	288	37	2.2k
Bowen Li China	29	1.1k 1.0×	786 1.2×	945 1.5×	464 1.0×	231 0.8×	84	2.5k
Yoshinori Koyama Japan	31	1.2k 1.1×	811 1.2×	1.4k 2.1×	439 1.0×	334 1.2×	76	3.4k
Longguang Tang China	30	1.2k 1.1×	660 1.0×	932 1.4×	383 0.9×	418 1.5×	62	2.5k
Jiyou Han South Korea	29	1.4k 1.3×	841 1.2×	1.0k 1.6×	357 0.8×	429 1.5×	58	2.8k
Haibin Shi China	25	1.3k 1.2×	657 1.0×	758 1.2×	237 0.5×	384 1.3×	76	2.2k
Lina Cui China	26	854 0.8×	693 1.0×	1.1k 1.6×	161 0.4×	436 1.5×	120	2.8k
Zhihe Liu China	30	1.1k 1.0×	1.3k 1.9×	789 1.2×	169 0.4×	168 0.6×	66	2.7k
Lei Xu China	28	647 0.6×	701 1.0×	1.3k 2.0×	221 0.5×	305 1.1×	93	2.8k
Ruslan I. Dmitriev Ireland	33	1.1k 1.0×	787 1.2×	1.0k 1.6×	175 0.4×	189 0.7×	99	3.2k

Countries citing papers authored by Erlong Zhang

Since Specialization

Citations

This map shows the geographic impact of Erlong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erlong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erlong Zhang more than expected).

Fields of papers citing papers by Erlong Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erlong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erlong Zhang. The network helps show where Erlong Zhang may publish in the future.

Co-authorship network of co-authors of Erlong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Erlong Zhang. A scholar is included among the top collaborators of Erlong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erlong Zhang. Erlong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Erlong, et al.. (2025). LiDAR-based optimization of UWB anchor deployment in tunnel environments. 37–37.

Li, Jianpo, et al.. (2025). Optimization of 5G base station deployment based on quantum genetic algorithm in outdoor 3D map. Computer Networks. 269. 111431–111431.

Xu, Yi‐Jun, Hui Dong, Zhaoxia Shi, et al.. (2025). All-DNA self-assembled G-Quadruplex/hemin DNAzyme nanosphere for ultrasensitive electrochemical detection of kanamycin residue. Sensors and Actuators B Chemical. 449. 139152–139152.

Xia, Yu, et al.. (2025). Multiple roles of ALDH1 in health and disease. Frontiers in Physiology. 16. 1627164–1627164. 1 indexed citations

Zhang, Erlong, et al.. (2024). Pose Estimation for Cross-Domain Non-Cooperative Spacecraft Based on Spatial-Aware Keypoints Regression. Aerospace. 11(11). 948–948. 1 indexed citations

Zhang, Erlong, et al.. (2023). Weak Spatial Target Extraction Based on Small-Field Optical System. Sensors. 23(14). 6315–6315. 3 indexed citations

Wang, Fuli, Yi‐Jun Wu, Chenxing Zhang, et al.. (2023). Study on the influence of node part on the bending behaviors of bamboo. Industrial Crops and Products. 204. 117384–117384. 5 indexed citations

Liu, Bao, Gang Xu, Shu He, et al.. (2022). Enhanced BPGM/2,3-DPG pathway activity suppresses glycolysis in hypoxic astrocytes via FIH-1 and TET2. Brain Research Bulletin. 192. 36–46. 3 indexed citations

He, Shu, Bao Liu, Gang Xu, et al.. (2021). Stanniocalcin-1 Protected Astrocytes from Hypoxic Damage Through the AMPK Pathway. Neurochemical Research. 46(11). 2948–2957. 12 indexed citations

10.

Gao, Yixing, Erlong Zhang, Bao Liu, et al.. (2019). Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma. Journal of Cellular and Molecular Medicine. 23(9). 6228–6237. 15 indexed citations

11.

Gao, Yixing, Bao Liu, Shu He, et al.. (2019). Targeting JUN, CEBPB, and HDAC3: A Novel Strategy to Overcome Drug Resistance in Hypoxic Glioblastoma. Frontiers in Oncology. 9. 33–33. 21 indexed citations

12.

Liu, Bao, He Huang, Gang Wu, et al.. (2017). A Signature of Circulating microRNAs Predicts the Susceptibility of Acute Mountain Sickness. Frontiers in Physiology. 8. 55–55. 23 indexed citations

13.

Liu, Bao, He Huang, Shouxian Wang, et al.. (2016). Physiological Adjustments and Circulating MicroRNA Reprogramming Are Involved in Early Acclimatization to High Altitude in Chinese Han Males. Frontiers in Physiology. 7. 601–601. 16 indexed citations

14.

Liao, Wenting, Bao Liu, Jian Chen, et al.. (2016). Metabolite Modulation in Human Plasma in the Early Phase of Acclimatization to Hypobaric Hypoxia. Scientific Reports. 6(1). 22589–22589. 38 indexed citations

15.

Wang, Yang, Tao Liu, Erlong Zhang, et al.. (2014). Preferential accumulation of the near infrared heptamethine dye IR-780 in the mitochondria of drug-resistant lung cancer cells. Biomaterials. 35(13). 4116–4124. 115 indexed citations

16.

Zhang, Erlong, Shenglin Luo, Xu Tan, & Chunmeng Shi. (2013). Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent. Biomaterials. 35(2). 771–778. 198 indexed citations

17.

Ding, Miao, et al.. (2013). Newly developed strategies for improving sensitivity to radiation by targeting signal pathways in cancer therapy. Cancer Science. 104(11). 1401–1410. 34 indexed citations

18.

Luo, Shenglin, Xu Tan, Qingrong Qi, et al.. (2012). A multifunctional heptamethine near-infrared dye for cancer theranosis. Biomaterials. 34(9). 2244–2251. 86 indexed citations

19.

Luo, Shenglin, Erlong Zhang, Yongping Su, Tianmin Cheng, & Chunmeng Shi. (2011). A review of NIR dyes in cancer targeting and imaging. Biomaterials. 32(29). 7127–7138. 1189 indexed citations breakdown →

20.

Zhang, Erlong, Chao Zhang, Yongping Su, Tianmin Cheng, & Chunmeng Shi. (2010). Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discovery Today. 16(3-4). 140–146. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact